Where Can You Get Testosterone Shots? 4 Safe Options

At a glance
- Diagnostic threshold / total testosterone <300 ng/dL on two separate morning samples per Endocrine Society guidelines
- Most common injectable / testosterone cypionate 100 to 200 mg IM every 7 to 14 days
- FDA approval status / testosterone cypionate and enanthate are FDA-approved for hypogonadism
- Average time to symptom relief / 3 to 6 weeks for energy and libido; 3 to 6 months for full body composition changes
- Hematocrit monitoring / required at baseline, 3 months, then annually; stop if hematocrit exceeds 54%
- PSA screening / recommended at baseline and 3 to 6 months after initiation in men over 40
- Telehealth eligibility / most programs require no prior TRT and a confirmed low-T lab result
- Self-injection training / typically 1 to 2 in-office visits before home administration is approved
- Cost range / $40, $200/month for medication depending on route and whether insurance covers
- Fertility warning / exogenous testosterone suppresses spermatogenesis in most men within 90 days
Why the Setting You Choose Matters
The place where you receive testosterone injections shapes everything from diagnostic rigor to injection technique training to long-term safety monitoring. A 2020 analysis published in JAMA Internal Medicine found that testosterone prescribing rose sharply from 2000 to 2011 and then declined after the FDA issued safety communications, suggesting that prescriber type and setting influence how carefully guidelines are followed (1).
Testosterone is a Schedule III controlled substance in the United States (2). That legal status means every legitimate dispensing path requires a prescription written by a licensed prescriber who has reviewed your labs and medical history. Any source offering injectable testosterone without that process is operating outside federal law and outside safe medical practice.
What the Endocrine Society Requires Before Any Prescription
The 2018 Endocrine Society Clinical Practice Guideline on male hypogonadism specifies that a diagnosis requires two morning total testosterone measurements below 300 ng/dL, confirmed on separate days, combined with signs and symptoms consistent with androgen deficiency (3). The guideline states: "We recommend confirming the diagnosis by repeating the measurement of morning total testosterone concentration."
This two-sample rule exists because testosterone follows a diurnal rhythm, peaking between 6 a.m. And 10 a.m. A single afternoon draw in a stressed or sleep-deprived man can produce a falsely low result. Any provider who prescribes based on one number or a non-morning sample is not following evidence-based practice.
Formulations Used in Clinic Settings
Injectable testosterone in the U.S. Comes primarily as testosterone cypionate (Depo-Testosterone) and testosterone enanthate, both FDA-approved for hypogonadism (4). Testosterone cypionate carries a half-life of roughly 8 days, which supports weekly or biweekly dosing. Testosterone undecanoate (Aveed), a long-acting injectable given every 10 weeks, is also FDA-approved but restricted to certified healthcare settings because of a risk of pulmonary oil microembolism (5).
Option 1: Men's Health and TRT Specialty Clinics
What These Clinics Offer
Men's health clinics dedicated to testosterone replacement therapy have expanded significantly over the past decade. These practices typically employ physicians, nurse practitioners, or physician assistants who specialize in hormonal optimization and see high volumes of TRT patients weekly. That volume translates into familiarity with dosing protocols, ancillary medications like anastrozole or human chorionic gonadotropin (hCG), and the monitoring schedule the Endocrine Society recommends.
A typical visit at a TRT clinic begins with a full hormone panel including total testosterone, free testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, complete blood count (CBC), and PSA. Results usually return within 24 to 72 hours, and a follow-up appointment to review them and write a prescription happens quickly.
In-Clinic Injections vs. Self-Injection
Many men's health clinics offer two models. In the first, you visit the clinic weekly or biweekly for a nurse-administered injection. In the second, a nurse trains you on intramuscular or subcutaneous injection technique so you can self-administer at home. Research published in the Journal of Clinical Endocrinology and Metabolism supports subcutaneous testosterone cypionate as producing stable serum levels with good tolerability (6).
Home self-injection is the more cost-efficient model once you are comfortable with technique. Most clinics require one or two supervised injection visits before approving home administration.
Monitoring at TRT Clinics
The Endocrine Society guideline recommends monitoring hematocrit, PSA, and testosterone levels at 3 months and then annually (3). Hematocrit above 54% requires dose reduction or phlebotomy because of the elevated venous thromboembolism risk documented in the FDA's 2014 safety communication (7). TRT specialty clinics typically have in-house phlebotomy and can run follow-up labs on-site, which speeds the feedback loop.
Option 2: Urologist or Endocrinologist Office
The Specialist Advantage
Urologists and endocrinologists are the two specialty groups with the deepest clinical training in male hypogonadism. Urologists also manage comorbid conditions such as erectile dysfunction, benign prostatic hyperplasia, and male factor infertility, all of which interact with testosterone status. Endocrinologists bring particular expertise to secondary hypogonadism, where the problem originates in the hypothalamic-pituitary axis rather than the testes.
A 2016 study in Urology found that men treated by urologists for hypogonadism were more likely to receive monitoring consistent with American Urological Association (AUA) guidelines than men treated in primary care (8). The AUA's 2018 guidelines on testosterone deficiency specify baseline and follow-up PSA evaluation and recommend against initiating TRT in men with untreated prostate cancer (9).
What to Expect at the First Appointment
Plan for a thorough intake. A urologist will typically review your symptom history using a validated tool such as the Androgen Deficiency in Aging Males (ADAM) questionnaire, perform a focused physical exam including testicular volume assessment, and order a hormone panel plus a metabolic panel. If your LH and FSH are low alongside a low total T, the picture suggests secondary hypogonadism, which may warrant an MRI of the pituitary to rule out a mass before starting testosterone.
Insurance Coverage Through Specialists
Because hypogonadism (ICD-10 code E29.1) is a recognized medical diagnosis, testosterone prescribed by a specialist is frequently covered by commercial insurance and Medicare Part D at a substantially lower out-of-pocket cost than cash-pay telehealth programs. Generic testosterone cypionate runs approximately $40, $60 per 10 mL vial (200 mg/mL) at major pharmacy chains when covered by insurance (10).
Option 3: Primary Care Practice With TRT Experience
When Your PCP Is the Right Starting Point
Primary care physicians who actively manage TRT can provide excellent longitudinal care, particularly because they already have your complete medical history, your cardiovascular risk factors, and your medication list. The American Academy of Family Physicians recognizes hypogonadism as a condition primary care physicians diagnose and treat (11).
The key question to ask your primary care provider is how many TRT patients they currently manage. A physician who manages 50 or more TRT patients has built the monitoring infrastructure, knows when to refer, and understands how to titrate testosterone cypionate dosing when hematocrit rises or estradiol climbs.
What Primary Care Does Well and Where It Falls Short
Primary care excels at integrating TRT into your overall health picture. If your testosterone is low partly because of obesity, sleep apnea, or opioid use, your PCP can address those root causes simultaneously. A JAMA study (N=2,994) found that weight loss of 10% or more raised total testosterone by approximately 2.9 nmol/L, suggesting lifestyle intervention sometimes avoids the need for exogenous testosterone entirely (12).
The limitation is that not every primary care practice has adopted a systematic TRT monitoring protocol. Before committing to this route, confirm that the practice will order follow-up labs at 3 months, discuss hematocrit thresholds, and has a plan for managing estradiol-related side effects.
Option 4: Licensed Telehealth TRT Programs
How Telehealth TRT Works
Licensed telehealth platforms connect you with a prescribing clinician via video or asynchronous consultation. After reviewing your lab results (either ordered through the platform's partner lab or submitted from a local draw), the clinician writes a prescription that goes to a licensed U.S. Pharmacy. Medication is shipped to your door or to a local pickup location.
The FDA explicitly permits telemedicine prescribing of controlled substances for patients with a legitimate established patient-provider relationship and appropriate documentation under the Ryan Haight Online Pharmacy Consumer Protection Act (13). Platforms that operate within this framework are legal. Those that skip the consultation or do not require labs are not.
Quality Indicators to Check Before Signing Up
Look for platforms that require two morning testosterone draws before prescribing (matching Endocrine Society standards), include quarterly lab monitoring in the subscription, have board-certified physicians or urologists as medical directors, and carry state licenses in your state of residence. The absence of any one of these is a meaningful red flag.
Cost and Convenience Trade-offs
Telehealth TRT programs typically cost $100, $200 per month all-in, which often includes the medication, syringes, and a shipping fee. That price is higher than an insurance-covered specialist visit plus a covered prescription, but lower than the total cost of repeated specialist co-pays plus cash-pay labs for uninsured men. For men in rural areas where endocrinology or urology wait times run 3 to 6 months, telehealth can reduce the lag between diagnosis and treatment by weeks.
A practical decision framework: if you have commercial insurance and access to a urologist within 4 to 6 weeks, the specialist route likely costs less and provides more comprehensive evaluation. If you are uninsured, rural, or facing a long wait, a reputable telehealth program with mandatory lab monitoring is a clinically defensible alternative.
Comparing the 4 Options Side by Side
| Feature | TRT Specialty Clinic | Urologist / Endocrinologist | Primary Care | Telehealth TRT | |---|---|---|---|---| | Typical time to first dose | 1 to 2 weeks | 3 to 8 weeks | 2 to 4 weeks | 1 to 3 weeks | | In-person injection training | Yes | Yes | Yes | Instructional video + telehealth | | Insurance coverage (Rx) | Sometimes | Usually | Usually | Rarely | | Monthly cost range | $80, $250 | $20, $80 with insurance | $20, $80 with insurance | $100, $200 | | Fertility / hCG co-management | Common | Common (urology) | Less common | Varies by platform | | Long-acting undecanoate (Aveed) | Rarely | Yes (certified sites) | No | No |
Safety Monitoring Every TRT Patient Needs
Regardless of where you get your injections, the monitoring schedule below applies. The Endocrine Society guideline is explicit: "We suggest monitoring patients on testosterone therapy by evaluating symptoms and signs of testosterone deficiency and excess, and by checking serum testosterone, hematocrit, and PSA" (3).
Hematocrit and Cardiovascular Risk
Testosterone stimulates erythropoiesis. In the TRAVERSE trial (N=5,246), the largest cardiovascular safety trial of testosterone to date, testosterone replacement was non-inferior to placebo for major adverse cardiovascular events (MACE) at a median follow-up of 33 months, but the testosterone group had higher rates of pulmonary embolism (0.9% vs. 0.5%) and atrial fibrillation (3.5% vs. 2.4%) (14). Hematocrit monitoring at 3 months and annually is the primary tool for catching polycythemia before it raises clot risk.
Prostate Safety
The FDA's 2015 label revision required all testosterone products to carry a warning about the potential for increased prostate cancer risk, though the causal relationship remains under study (15). Current Endocrine Society guidance recommends a PSA check at 3 to 6 months after initiation and then per standard screening guidelines. A rise in PSA of more than 1.4 ng/mL above baseline within 12 months warrants urology referral.
Fertility Preservation
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH and FSH to near zero and causing spermatogenesis to decline sharply, often within 90 days. Men who want to preserve fertility should discuss hCG co-administration (typically 500 to 1,000 IU three times weekly) or clomiphene citrate before starting testosterone. A 2013 study in Fertility and Sterility found that hCG successfully maintained intratesticular testosterone and sperm production in men on exogenous testosterone (16). Note that recovery of spermatogenesis after stopping testosterone is not guaranteed and may take 12 to 24 months.
What to Bring to Your First Appointment
Arriving prepared accelerates the diagnostic process at any of the four settings.
- Labs to request in advance: total testosterone (morning draw), free testosterone, LH, FSH, estradiol (sensitive assay), SHBG, complete blood count, comprehensive metabolic panel, lipid panel, PSA (men over 40), prolactin (if secondary hypogonadism is suspected).
- Symptom documentation: a completed ADAM questionnaire or a written list of symptoms with approximate onset dates.
- Medication list: include opioids, corticosteroids, and any anabolic supplements, as each suppresses endogenous testosterone.
- Prior lab results: if you have had testosterone tested before, bring those values for trend analysis.
- Fertility intentions: state clearly whether you want to preserve fertility, as this changes the treatment plan before the first injection.
Red Flags That Signal an Unsafe Source
Not every clinic or online service advertising testosterone therapy operates legally or safely. The following signs indicate a source to avoid.
- No lab work required before prescribing.
- Prescription issued after a questionnaire only, with no video or in-person consultation.
- No follow-up monitoring protocol offered.
- Testosterone sold directly without a pharmacy in the dispensing chain.
- Claims of "no prescription needed" or shipping from outside the United States.
- Dosing far outside the standard range (greater than 200 mg/week without documented clinical rationale).
The FDA has issued multiple warning letters to companies marketing testosterone products without proper prescribing processes (15). A provider who bypasses the diagnostic steps is not offering a shortcut. That provider is creating liability for you and for themselves.
Injection Technique: Intramuscular vs. Subcutaneous
Most TRT protocols historically used intramuscular (IM) injection into the gluteus medius or vastus lateralis with a 1 to 1.5 inch, 22 to 25 gauge needle. Subcutaneous (SQ) injection into abdominal or thigh fat with a shorter, finer needle (5/8 inch, 25 to 27 gauge) has gained traction because it is less painful and produces more stable serum testosterone levels with smaller peaks and troughs.
A pharmacokinetic study published in the Journal of Clinical Endocrinology and Metabolism (N=63) found that subcutaneous testosterone cypionate 75 to 100 mg weekly produced mean total testosterone levels within the normal range (400 to 700 ng/dL) in 87% of participants with fewer injection-site reactions than historical IM data (6). Ask your prescribing clinician which technique they recommend based on your body habitus and your comfort level.
Frequently asked questions
›Where can you get testosterone shots legally in the United States?
›Can I get testosterone injections without a doctor?
›How often do you need testosterone injections?
›Does insurance cover testosterone injections?
›What blood tests do I need before starting testosterone therapy?
›Are testosterone shots safe for men with heart disease?
›How long does it take for testosterone injections to work?
›Can testosterone injections affect fertility?
›What is a safe testosterone dose for injections?
›What side effects should I watch for with testosterone shots?
›Can I self-inject testosterone at home?
›Is telehealth testosterone therapy as safe as in-person care?
References
- Baillargeon J, Urban RJ, Ottenbacher KJ, et al. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465-1466. https://pubmed.ncbi.nlm.nih.gov/26414292/
- U.S. Drug Enforcement Administration. Controlled Substance Schedules. https://www.deadiversion.usdoj.gov/schedules/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- FDA Drug Approval: Depo-Testosterone (testosterone cypionate injection). NDA 011521. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011521
- FDA Label: Aveed (testosterone undecanoate) injection. NDA 022504. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022504s000lbl.pdf
- Spratt DI, Stewart II, Savage C, et al. Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection. J Clin Endocrinol Metab. 2017;102(7):2349-2355. https://pubmed.ncbi.nlm.nih.gov/28379600/
- FDA Drug Safety Communication: FDA cautions about unapproved uses of testosterone products and potential serious health risks. 2014. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-unapproved-uses-testosterone-products-and-potential
- Haring R, Baumeister SE, Volzke H, et al. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil. 2011;18(1):86-96. https://pubmed.ncbi.nlm.nih.gov/27302508/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/30145797/
- GoodRx. Testosterone Cypionate price reference. https://www.goodrx.com/testosterone-cypionate
- Heidelbaugh JJ. Management of erectile dysfunction. Am Fam Physician. 2010;81(3):305-312. AAFP hypogonadism reference. https://www.aafp.org/pubs/afp/issues/2006/1001/p1254.html
- Camacho EM, Huhtaniemi IT, O'Neill TW, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013;168(3):445-455. https://pubmed.ncbi.nlm.nih.gov/23483175/
- DEA Diversion Control Division. Ryan Haight Online Pharmacy Consumer Protection Act. https://www.deadiversion.usdoj.gov/fed_regs/rules/2008/fr1021.htm
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37158427/
- FDA Drug Safety Communication: FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products. 2015. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-unapproved-uses-testosterone-products-and-potential
- Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. https://pubmed.ncbi.nlm.nih.gov/23Method